Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol

INTRODUCTION: Within the last two decades, major advances have been made in the surgical approach for patients with colorectal cancer. However, to this day we face considerable challenges in reducing surgery-related complications and improving long-term oncological outcomes. Unprecedented response r...

Descripción completa

Detalles Bibliográficos
Autores principales: Justesen, Tobias Freyberg, Gögenur, Ismail, Tarpgaard, Line Schmidt, Pfeiffer, Per, Qvortrup, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314641/
https://www.ncbi.nlm.nih.gov/pubmed/37349100
http://dx.doi.org/10.1136/bmjopen-2023-073372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314641/
https://www.ncbi.nlm.nih.gov/pubmed/37349100
http://dx.doi.org/10.1136/bmjopen-2023-073372

Ejemplares similares